Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Charles Cantor to Give Plenary Keynote at GTC’s Biomarker Summit, March 20-22 in San Francisco, California - Charles Cantor, Chief Scientific Officer at Sequenom Will Be Giving a Plenary Keynote Presentation Entitled “Non-invasive Personalized Genomics” at GTC’s Biomarker Summit 2013, Taking Place in San Francisco, CA on March 20–22
Charles Cantor to Give Plenary Keynote at GTC’s Biomarker Summit, March 20-22 in San Francisco, California

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2012/12/04 - Charles Cantor, Chief Scientific Officer at Sequenom Will Be Giving a Plenary Keynote Presentation Entitled “Non-invasive Personalized Genomics” at GTC’s Biomarker Summit 2013, Taking Place in San Francisco, CA on March 20–22.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In a variety of clinical settings nucleic acids from apoptotic or broken cells appear in the peripheral circulation. These are potential sources of diagnostic markers. In DNA biomarkers, clinically useful information can be derived from the sequences present, from specific mutations and epigenetic modifications not present in the normal plasma DNA of a healthy host.

One case of interest is non-invasive prenatal diagnostics. Commercial tests using highly parallel DNA sequencing have been available for more than a year to detect aneuploidies and the performance of these tests is nearly perfect. Indeed it is possible, but not yet commercially practical, to determine the entire genomic sequence of an unborn fetus by analysis of sufficient numbers of apoptotic DNA fragments in maternal plasma. Cancer presents a parallel situation since tumors have DNA sequences and epigenetic patterns not found in the normal host.

Dr. Cantors talk will present on:
- a state of the art technology for biomarkers
- cutting edge diagnostic products
- studying the root cause of clinical phenotypes.

Dr. Charles Cantor is a founder and Chief Scientific Officer at SEQUENOM, Inc. He is also professor emeritus of Biomedical Engineering and of Pharmacology and was the director of the Center for Advanced Biotechnology at Boston University. He is currently adjunct professor of Bioengineering at UC San Diego, adjunct professor of Molecular Biology at the Scripps Institute for Research, and distinguished adjunct professor of Physiology and Biophysics at UC Irvine.

Dr. Cantor has been granted more than 60 US patents and has published more than 450 peer-reviewed articles, and is a member of the U.S. National Academy of Sciences.

The Biomarker Summit 2013 provides a unique opportunity to gain the latest biomarker developments in three major therapeutic areas, formally organized in the following tracks:

• 6th Oncology Biomarkers
• 2nd Neurological Biomarkers
• 2nd Inflammatory & Immunological Biomarkers

The summit will discuss a wide range of issues such as biomarker identification and validation strategies, patient stratification, enabling omics technologies, bioinformatics and systems biology techniques, regulatory and reimbursement trends and the development of companion diagnostics. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Charles Cantor to Give Plenary Keynote at GTC’s Biomarker Summit, March 20-22 in San Francisco, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  1Click Games

Visit  Intrinsic Executive Search Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today